Explore how killer cells and low-dose interleukin-2 are transforming cancer immunotherapy through adoptive cell transfer and cytokine strategies.
Discover how cancer immunotherapy is revolutionizing treatment by harnessing the body's own immune system to fight cancer with precision and effectiveness.
Explore how the Raji-Burkitt's lymphoma model is advancing CD52-targeted immunotherapies and revolutionizing cancer treatment approaches.